Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ZX2021 injection in non-diabetic overweight or obese adults
CTR20250527Phase 2Active
- Sponsor
- Jiangsu Zhongxin Pharmaceutical
- Start
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ZX2021 in obesity, Overweight, sponsored by Jiangsu Zhongxin Pharmaceutical. Started Jun 2025; status: active.
02
Drugs
ZX2021
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20250527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250527.